🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
HS-20117 is a fully-human EGFR-MET immunoglobulin G1(IgG1)-like bispecific ...
Status
Not Yet Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2023-07-20
Trial ID
NCT05940116
Treatments Being Tested
This trial is a multicenter, open-label, Phase I clinical study designed to...
Status
Recruiting
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2025-11-13
Trial ID
NCT07775703
Treatments Being Tested
This is a multi-center, open-label, phase I study to evaluate the safety, e...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-30
Trial ID
NCT07414953
This is a Phase Ib study that will evaluate the Safety, Tolerability , Phar...
Status
Not Yet Recruiting
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2025-05-30
Trial ID
NCT06963502
HS-20117 is a fully-human EGFR-MET immunoglobulin G1(IgG1)-like bispecific ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2024-05-28
Trial ID
NCT06417008
Treatments Being Tested
HS-20117 is a fully-human EGFR-MET immunoglobulin G1(IgG1)-like bispecific ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute & Hospital
Start Date
2024-12-14
Trial ID
NCT06621563